Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Med Chem ; 63(13): 7369-7391, 2020 07 09.
Artículo en Inglés | MEDLINE | ID: mdl-32515588

RESUMEN

The hallmark of joint diseases, such as osteoarthritis (OA), is pain, originating from both inflammatory and neuropathic components, and compounds able to modulate the signal transduction pathways of the cannabinoid type-2 receptor (CB2R) can represent a helpful option in the treatment of OA. In this perspective, a set of 18 cannabinoid type-2 receptor (CB2R) ligands was developed based on an unprecedented structure. With the aim of improving the physicochemical properties of previously reported 4-hydroxy-2-quinolone-3-carboxamides, a structural optimization program led to the discovery of isosteric 7-hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide derivatives. These new compounds are endowed with high affinity for the CB2R and moderate to good selectivity over the cannabinoid type-1 receptor (CB1R), associated with good physicochemical characteristics. As to the functional activity at the CB2R, compounds able to act either as agonists or as inverse agonists/antagonists were discovered. Among them, compound 51 emerged as a potent CB2R agonist able to reduce pain in rats carrying OA induced by injection of monoiodoacetic acid (MIA).


Asunto(s)
Antiasmáticos/farmacología , Condrocitos/efectos de los fármacos , Osteoartritis/tratamiento farmacológico , Receptor Cannabinoide CB2/metabolismo , 4-Quinolonas/química , Animales , Antiasmáticos/química , Células CHO , Agonistas de Receptores de Cannabinoides/síntesis química , Agonistas de Receptores de Cannabinoides/farmacología , Condrocitos/metabolismo , Condrocitos/patología , Colforsina/farmacología , Cricetulus , Modelos Animales de Enfermedad , Diseño de Fármacos , Evaluación Preclínica de Medicamentos/métodos , Humanos , Ácido Yodoacético/toxicidad , Ligandos , Masculino , Ratones , Células 3T3 NIH , Osteoartritis/inducido químicamente , Ratas Wistar , Receptor Cannabinoide CB1/genética , Receptor Cannabinoide CB1/metabolismo , Receptor Cannabinoide CB2/agonistas , Receptor Cannabinoide CB2/antagonistas & inhibidores , Receptor Cannabinoide CB2/genética , Relación Estructura-Actividad , Caminata
2.
Food Chem ; 262: 56-66, 2018 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-29751921

RESUMEN

In this study the antioxidant effect of Cannabis sativa L. seeds and sprouts (3 and 5 days of germination) was evaluated. Total polyphenols, flavonoids and flavonols content, when expressed on dry weight basis, were highest in sprouts; ORAC and DPPH (in vitro assays), CAA-RBC (cellular antioxidant activity in red blood cells) and hemolysis test (ex vivo assays) evidenced a good antioxidant activity higher in sprouts than in seeds. Untargeted analysis by high resolution mass spectrometry in negative ion mode allowed the identification of main polyphenols (caffeoyltyramine, cannabisin A, B, C) in seeds and of ω-6 (linoleic acid) in sprouts. Antimutagenic effect of seeds and sprouts extracts evidenced a significant decrease of mutagenesis induced by hydrogen peroxide in Saccharomyces cerevisiae D7 strain. In conclusion our results show that C. sativa seeds and sprouts exert beneficial effects on yeast and human cells and should be further investigated as a potential functional food.


Asunto(s)
Antimutagênicos/farmacología , Antioxidantes/farmacología , Cannabis/química , Suplementos Dietéticos , Semillas/química , Antimutagênicos/análisis , Antioxidantes/análisis , Suplementos Dietéticos/análisis , Eritrocitos/efectos de los fármacos , Flavonoides/análisis , Flavonoides/farmacología , Flavonoles/análisis , Flavonoles/farmacología , Germinación , Humanos , Peróxido de Hidrógeno/toxicidad , Polifenoles/análisis , Polifenoles/farmacología , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/genética
3.
J Med Chem ; 60(12): 5216-5221, 2017 06 22.
Artículo en Inglés | MEDLINE | ID: mdl-28525717

RESUMEN

LDN-212320 (3) was found to be a potent EAAT2 activator at a translational level, restoring the normal clearance of glutamate and providing neuronal protection. Since the pharmacologic activation of EAAT2 represents a valuable strategy to relieve neuropathic pain, we synthesized novel activators (4a-f) of EAAT2. Among them 4f, analyzed in comparison with 3 by different paradigms in a rat model of oxaliplatin-induced neuropathic pain, showed the better antihypersensitive profile being able to fully counteract the oxaliplatin-induced neuropathy.


Asunto(s)
Evaluación Preclínica de Medicamentos/métodos , Proteínas de Transporte de Glutamato en la Membrana Plasmática/metabolismo , Fármacos Neuroprotectores/química , Fármacos Neuroprotectores/farmacología , Piridazinas/química , Piridinas/farmacología , Animales , Técnicas de Química Sintética , Transportador 2 de Aminoácidos Excitadores , Masculino , Neuralgia/inducido químicamente , Neuralgia/tratamiento farmacológico , Fármacos Neuroprotectores/síntesis química , Compuestos Organoplatinos/toxicidad , Oxaliplatino , Piridazinas/síntesis química , Piridazinas/farmacología , Piridinas/química , Ratas Sprague-Dawley
4.
Artículo en Inglés | MEDLINE | ID: mdl-27592168

RESUMEN

The aims of this study were to highlight the impact of minor structural differences (e.g. an aminoacid side chain enlargement by one methylene group), on ion dissociation under collision-induced dissociation conditions, and to determine the underlying chemical mechanisms. Therefore, we compared fragmentations of deprotonated aspartic and glutamic acids generated in negative electrospray ionization. Energy-resolved mass spectrometry breakdown curves were recorded and MS3 experiments performed on an Orbitrap Fusion for high-resolution and high-mass accuracy measurements. Activated fragmentations were performed using both the resonant and non-resonant excitation modes (i.e., CID and HCD, respectively) in order to get complementary information on the competitive and consecutive dissociative pathways. These experiments showed a specific loss of ammonia from the activated aspartate but not from the activated glutamate. We mainly focused on this specific observed loss from aspartate. Two different mechanisms based on intramolecular reactions (similar to those occurring in organic chemistry) were proposed, such as intramolecular elimination (i.e. Ei-like) and nucleophilic substitution (i.e. SNi-like) reactions, respectively, yielding anions as fumarate and α lactone from a particular conformation with the lowest steric hindrance (i.e. with antiperiplanar carboxyl groups). The detected deaminated aspartate anion can then release CO2 as observed in the MS3 experimental spectra. However, quantum calculations did not indicate the formation of such a deaminated aspartate product ion without loss of carbon dioxide. Actually, calculations displayed the double neutral (NH3+CO2) loss as a concomitant pathway (from a particular conformation) with relative high activation energy instead of a consecutive process. This disagreement is apparent since the concomitant pathway may be changed into consecutive dissociations according to the collision energy i.e., at higher collision energy and at lower excitation conditions, respectively. The latter takes place by stabilization of the deaminated aspartate solvated with two residual molecules of water (present in the collision cell). This desolvated anion formed is an α lactone substituted by a methylene carboxylate group. The vibrational excitation acquired by [(D-H)-NH3]-during its isolation is enough to allow its prompt decarboxylation with a barrier lower than 8.4kJ/mol. In addition, study of glutamic acid-like diastereomers constituted by a cyclopropane, hindering any side chain rotation, confirms the impact of the three-dimensional geometry on fragmentation pathways. A significant specific loss of water is only observed for one of these diastereomers. Other experiments, such as stable isotope labeling, need to be performed to elucidate all the observed losses from activated aspartate and glutamate anions. These first mechanistic interpretations enhance understanding of this dissociative pathway and underline the necessity of studying fragmentation of a large number of various compounds to implement properly new algorithms for de novo elucidation of unknown metabolites.


Asunto(s)
Ácido Aspártico/química , Ácido Glutámico/química , Protones , Amoníaco/química , Aniones/química , Dióxido de Carbono/química , Modelos Moleculares , Conformación Molecular , Espectrometría de Masa por Ionización de Electrospray/métodos , Estereoisomerismo , Agua/química
5.
ChemMedChem ; 5(5): 739-48, 2010 May 03.
Artículo en Inglés | MEDLINE | ID: mdl-20379990

RESUMEN

A small set of aggrecanase inhibitors based on the pyrrolo[3,4-c]quinolin-1-one or oxoisoindoline frameworks bearing a 4-(benzyloxy)phenyl substituent and different zinc binding groups were rationally designed and evaluated in silico by docking studies using the crystal structure of the ADAMTS-5 catalytic domain (PDB code: 3B8Z). The designed compounds were synthesized via straightforward routes and tested for their potential inhibitory activity against ADAMTS-5 and ADAMTS-4. Among the compounds containing the pyrrolo[3,4-c]quinolinone tricyclic system, hydroxamate derivative 2 b inhibited both ADAMTS-5 and ADAMTS-4, with IC(50) values in the submicromolar range and an inhibitory profile very similar to that of reference carboxylate derivative 11. Conversely, the corresponding carboxylate derivative 2 a was significantly less active and unable to discriminate between ADAMTS-5 and -4. The structure-activity relationship analysis of pyrroloquinolinone derivatives 2 a-i suggests that the carboxylate or hydroxamate groups of compounds 2 a,b play a key role in the interaction of these compounds with ADAMTS-5 and -4. On the other hand, the oxoisoindoline derivatives 3 a,b lack significant ADAMTS-4 inhibitory activity and inhibit ADAMTS-5 showing IC(25) values in the micromolar range.


Asunto(s)
Endopeptidasas/química , Indoles/química , Inhibidores de Proteasas/síntesis química , Quinolonas/química , Proteínas ADAM/química , Sitios de Unión , Dominio Catalítico , Simulación por Computador , Cristalografía por Rayos X , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Endopeptidasas/metabolismo , Indoles/síntesis química , Indoles/farmacología , Conformación Molecular , Inhibidores de Proteasas/química , Inhibidores de Proteasas/farmacología , Quinolonas/síntesis química , Quinolonas/farmacología
7.
Oncol Res ; 15(2): 69-79, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16119004

RESUMEN

The aim of the present study was to determine whether the expression of the estrogen receptor alpha (ERalpha) gene may be a possible target for compounds present in plant extracts from Aegle marmelos and Emblica officinalis, used in traditional Asian medicine in the treatment of tissue inflammation and cancer. To this aim, we evaluated the potential of the selected plant extracts to affect proliferation and differentiation of ERalpha-negative MDA-MB-231 breast cancer cells, which become ERalpha positive after treatment with a decoy molecule against a regulatory region of the human ERalpha gene. All the plant extracts inhibited cell proliferation and showed no effect on ERalpha gene expression, but when they were added in combination with the decoy molecule, a modulatory effect was observed, depending on the extract employed. The extracts exhibiting the greatest effects were those obtained from Aegle marmelos. Gas-chromatography/mass-spectrometry (GC/ MS) analysis enabled us to identify lupeol, a known triterpenoid, as the major bioactive component of A. marmelos plant extracts. Similar to the Aegle marmelos extracts, lupeol was found to stimulate the decoy effect of RA4 DNA sequence, increasing at a high level ERa gene expression in MDA-MB-231 ERalpha-negative breast cancer cells, and also inhibited cell proliferation.


Asunto(s)
Neoplasias de la Mama/metabolismo , Receptor alfa de Estrógeno/biosíntesis , Receptor alfa de Estrógeno/genética , Regulación Neoplásica de la Expresión Génica , Extractos Vegetales/metabolismo , Factores de Transcripción/metabolismo , Línea Celular Tumoral , Proliferación Celular , Cromatografía de Gases , Receptor alfa de Estrógeno/metabolismo , Cromatografía de Gases y Espectrometría de Masas , Humanos , Inmunohistoquímica , Espectrometría de Masas , Modelos Químicos , Triterpenos Pentacíclicos , Fenotipo , Extractos Vegetales/uso terapéutico , Plantas Medicinales , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Tiempo , Transfección , Triterpenos/química , Triterpenos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA